These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8393212)

  • 1. [Fc receptor blockade in patients with chronic refractory autoimmune thrombocytopenia].
    Ruiz-Argüelles GJ; Ruiz-Argüelles A; Marín-López A
    Rev Invest Clin; 1993; 45(2):182-3. PubMed ID: 8393212
    [No Abstract]   [Full Text] [Related]  

  • 2. A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura.
    Estrada-Gómez R; Vargas-Castro O; Oropeza-Borges M; González-Carrillo ML; Pérez-Romano B; Ruiz-Argüelles GJ
    Rev Invest Clin; 2007; 59(6):424-7. PubMed ID: 18402333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
    Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose autologous in vitro opsonized erythrocytes. Radioimmune method and autologous opsonized erythrocytes for refractory autoimmune thrombocytopenic purpura in adults.
    Ambriz R; Muñóz R; Pizzuto J; Quintanar E; Morales M; Avilés A
    Arch Intern Med; 1987 Jan; 147(1):105-8. PubMed ID: 3026270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-D treatment in thrombocytopenia refractory to conventional therapies.
    Adorno G; Lo Pinto FR; Cox MC; Bruno A; Masi M; Stipa E; Montanaro M; Papa G
    Haematologica; 1992; 77(1):97-8. PubMed ID: 1327999
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
    Crow AR; Lazarus AH
    Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura.
    Delgado J; Bustos JG; Jimenez-Yuste V; Hernandez-Navarro F
    Haematologica; 2002 Feb; 87(2):215-6. PubMed ID: 11836172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-D: lack of efficiency due to absence of Fc gammaR-inhibiting activity?
    Neppert J; von Witzleben-Schürholz EM
    Transfusion; 1997 Apr; 37(4):444-5; author reply 445-6. PubMed ID: 9111285
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune complexes as therapy for autoimmunity.
    Clynes R
    J Clin Invest; 2005 Jan; 115(1):25-7. PubMed ID: 15630438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An affordable Fc-receptor blockade method to treat patients with chronic refractory autoimmune thrombocytopenic purpura.
    Ruiz-Argüelles GJ; López-Martínez B; Flores-Martínez J; Ruiz-Argüelles A; Pérez-Romano B
    Haematologica; 2001 May; 86(5):552-3. PubMed ID: 11410427
    [No Abstract]   [Full Text] [Related]  

  • 14. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
    Mehta YS; Badakere SS
    J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The bases for and the applications of intravenous gamma globulins in the treatment of autoimmune cytopenias].
    Dasi Carpio MA
    An Esp Pediatr; 1991 Dec; 35 Suppl 47():93-6. PubMed ID: 1821609
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR; Song S; Siragam V; Lazarus AH
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
    Song S; Crow AR; Freedman J; Lazarus AH
    Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic immune thrombocytopenic purpura in children and adults.
    Blanchette V; Freedman J; Garvey B
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Splenic irradiation as a treatment for chronic idiopathic thrombocytopenic purpura].
    Cancelas JA; Alvarez F; Navarro JL; César JM
    Sangre (Barc); 1994 Apr; 39(2):152-3. PubMed ID: 8059297
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma.
    Shvidel L; Klepfish A; Berrebi A
    Am J Hematol; 2001 Jul; 67(3):213-4. PubMed ID: 11391724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.